Issue link: http://osercommunicationsgroup.uberflip.com/i/247183
AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS Sunday, August 11, 2013 CRUNCHIES GOES LOONEY TUNES In a deal that's sure to animate the kids' health food industry, Crunchies Food Company, LLC – the leading producer of all-natural freeze-dried fruits and vegetables – has joined with Warner Bros. Consumer Products (WBCP) to create a new line of better-for-you snacks for kids: Little Crunchies®. Introduced at Natural Continued on Page 52 RANBAXY CONTINUES PORTFOLIO GROWTH Oser Communications Group EMPOWERED PRODUCTS CARVES OUT SHELF SPACE IREFILL CONNECT IMPROVES PATIENT COMMUNICATION An interview with Scott Fraser, President and C E O , Empowered Products, Inc. An interview with Val Gurovich, President and C T O , Te l e M a n a g e r Technologies, Inc. SF: Empowered Products develops, manufactures, markets and sells 17 SKUs in two VG: Chain pharmacies face the challenge of providing their patients with modern communications options which are Continued on Page 50 Continued on Page 52 CDD: How extensive and competitive is your personal lubricant product line today? H.D. SMITH EXPANDS TO MEET CUSTOMER NEEDS Ranbaxy entered the U.S. dermatology market in 2003, when it launched a generic version of the brandname treatment Accutane, but in a new dosage that it thought would be more convenient for many patients. Over the years, Ranbaxy has expanded and deepened its dermatology portfolio, as was demonstrated when the company Since its founding in 1954, H. D. Smith has grown from a regional pharmaceutical wholesaler to the country's fourthlargest pharmaceutical wholesaler – but one thing hasn't changed: its commitment to customers. From manufacturers to retail pharmacists, institutions to long-term care facilities, and alternate sites of care Continued on Page 52 Continued on Page 69 CD: Are there any communication challenges facing chain pharmacies today? WITNESS THE NEW ACTAVIS An interview with Andy Boyer, Actavis Senior Vice President, U.S. Generics Sales & Marketing. Las Vegas AMNEAL: THE ANTIDOTE TO THE PATENT CLIFF Chirag Patel, President and Co-Chairman o f A m n e a l Pharmaceuticals, LLC, talks about the company's emergence as a generics market leader through its expansion into high value, differentiated products. CDD: Amneal continues to build on its reputation as a leading U.S. developer, If you walk into any chain drug store, mass merchandiser, or supermarket HBC section you will find hundreds of products that David Biernbaum and his teams have influenced, placed, developed and grown to lasting success over a period of many years. Biernbaum; a marketing expert, sales and business development consultant, and Continued on Page 69 Continued on Page 50 INNOVACYN MOVES FORWARD IN HEALTH PRODUCTS AB: The new Actavis (NYSE: ACT) is a combination of Watson Pharmaceuticals, Inc. and Actavis Group. Following Innovacyn, Inc. is a privately-held American company formed to provide premier healthcare products. Innovacyn embraces scientific research to deliver innovative products and world-class operations to consumers of the human and animal healthcare industries. Innovacyn wound and skin care products are marketed in both the human and animal health care markets. Innovacyn Continued on Page 69 Continued on Page 47 CDD: Tell us about rebranding a global leader. DAVID BIERNBAUM: A TRACK RECORD OF EXPERIENCE EVERY CINSULIN HOLDS 60 YEARS OF VITATECH QUALITY An interview with Tom T i e r n e y , President and CEO of Vitatech Nutritional Sciences, Inc. CDD: Tell our readers about your company. What is your main line of business? TT: Vitatech Nutritional Sciences Inc is a premier health sciences formulation and Continued on Page 50